Therefore, our results reveal the role of CTHRC1 in CAFs in pancreatic cancer, and the CTHRC1/LIF/STAT3 signaling axis may be a promising prognostic marker and therapeutic target for patients with pancreatic cancer. Here, CTHRC1 is linked to pancreatic neoplasm.